In a Chinese study, the combination of thoracic RT and TKIs for stage IV EGFR mutated NSCLC, found that grade 3 or superior adverse events were radiation pneumonitis and rash, frequently very well controlled by corticosteroids administration [59]. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.